Beta bionics CCO sells $3,385 in shares

Created at 5 Jun · 22:32 UTC2 sources2 events

IN SHORT

Beta bionics Chief Commercial Officer Mark Hopman sold 3,385 shares of the company's stock, valued at $3,385. This follows a previous sale by director Jones Christy.

Key Numbers

3,385 sharesshares sold by CCO

$3,385total transaction value

Who's Involved

Mark Hopman

Chief Commercial Officer at Beta bionics who sold shares

Beta bionics

Company whose stock was sold

Key facts

Beta bionics CCO Mark Hopman sold 3,385 shares.
The total value of the transaction was $3,385.

Beta bionics Chief Commercial Officer Mark Hopman has sold 3,385 shares of the company's stock. The total value of this transaction amounts to $3,385. This event follows a recent stock sale by Beta bionics director Jones Christy.

↳ Why This Matters

Insider selling can sometimes signal a lack of confidence in future stock performance, although it can also be for personal financial planning reasons.

FREQUENTLY ASKED

Mark Hopman is the Chief Commercial Officer at Beta bionics.

He sold 3,385 shares of Beta bionics stock for a total of $3,385.

Beta bionics is a company whose stock was involved in the transaction.

Get the newsletter.

Pick the topics you actually care about. We'll email when there's news worth your time, on the cadence you choose. Cancel any time from your account.

Cadence

CME Headlines

Clearing Confirm MQ Connection Migration - Effective June 05, 2026

Beta bionics CCO sells $3,385 in shares

PiQ Daily

Key facts

Get the newsletter.

Beta bionics CCO sells $3,385 in shares

PiQ Daily

Key facts

Get the newsletter.